Therapeutic
University partners find MND therapy potential
Researchers announced in August 2022 that they found evidence that the drug terazosin “protects against the death of motor neurons”.
Immune system map uncovers therapeutic potential
A group of scientists, led by researchers at the Wellcome Sanger Institute and ETH Zurich, created a “comprehensive map” of the connections…
Improving protein factories for gene therapies
Gene therapy tackles the source of disease in the patient’s DNA through viral or bacterial vectors. Most commonly, muscle cells are targeted
Vertex’s “Fantasy project” with Moderna pushes CF limits
Vertex Pharmaceuticals and Moderna announced in 2022 their collaboration aimed at the “discovery and development of lipid nanoparticles (LNPs) and mRNAs”.
2030 AIDS elimination goals for new WHO alliance
The recent UNAIDS report revealed that only 52% of children with HIV are receiving life-saving treatment. This number is a far below the adult population.
Does EBV hold the key for Multiple Sclerosis?
Multiple Sclerosis (MS) affects the CNS in among 2.8 million people worldwide. The front runner among causal agents is Epstein-Barr virus (EBV), a human herpesvirus. It is present in around 90% of adults by the age of 35. Early studies support the link between EBV and...
Fighting hidden threats: vaccines against cancer?
Vaccines provide the immune system with information to recognise and fight threats before they appear in the body. Although we associate vaccines with infectious diseases the cancer field is growing more effective. In the1890s William Coley reported that injecting...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
